Table 1 Correlation between MIR99AHG expression and clinicopathological characteristics of GC
Clinical parameter | MIR99AHG | Expression | P-value |
|---|---|---|---|
High no. cases (n = 59) | Low no. cases (n = 59) | ||
Age (years) | 0.732 | ||
≤ 50 | 31 | 36 | |
> 50 | 28 | 23 | |
Gender | 0.554 | ||
Male | 37 | 33 | |
Female | 22 | 27 | |
Location | 0.679 | ||
Distal | 20 | 24 | |
Middle | 21 | 23 | |
Proximal | 18 | 12 | |
Size (cm) | 0.654 | ||
> 5 | 35 | 33 | |
≤ 5 | 29 | 31 | |
Histologic differentiation | 0.008 | ||
Well | 9 | 13 | |
Moderately | 17 | 20 | |
Poorly | 21 | 10 | |
Undifferentiated | 12 | 16 | |
Invasion depth | < 0.001 | ||
T1 | 4 | 15 | |
T2 | 10 | 21 | |
T3 | 20 | 15 | |
T4 | 15 | 8 | |
TNM stages | 0.003 | ||
I–II | 20 | 35 | |
III–IV | 39 | 24 | |
Lymphatic metastasis | < 0.001 | ||
Yes | 39 | 23 | |
No | 20 | 36 | |
Distant metastasis | 0.02 | ||
Yes | 15 | 7 | |
No | 44 | 52 | |